PROVIDER PROFILE · NPI 1356536031

Nilda Guerra-CavazosMD

Family PracticeSan Antonio, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

138

Distinct HCPCS

Medicare payment

$6K

Peer benchmark

Total Medicare services vs. 6,385 Family Practice providers in TX — bottom quintile (cohort median 567).

PRESCRIBING · PART D · 2024

Total Rx claims

9,889

Beneficiaries

—

Total drug cost

$1.1M

Distinct drugs

136

Brand share

24.6%

Top prescribed drugs

Atorvastatin Calcium654 claims

Hydrocodone/Acetaminophen454 claims

Amlodipine Besylate366 claims

Levothyroxine Sodium327 claims

Lisinopril316 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$26

Payment records

By payment type

Food and Beverage$26

REFERRAL NETWORK

Where Nilda Guerra-Cavazos's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 6 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
METHODIST HEALTHCARE SYSTEM OF SAN ANTONIO, LTD., L.L.P.	14	25

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
EL CENTRO DEL BARRIO, INC.	164	503
Laboratory Corporation Of America Clinical Laboratory · Houston, TX	42	72
BEXAR COUNTY HOSPITAL DISTRICT	38	147
VHS SAN ANTONIO PARTNERS LLC	16	46
Laboratory Corporation Of America Holdings Clinical Laboratory · Burlington, NC	14	27
METHODIST HEALTHCARE SYSTEM OF SAN ANTONIO, LTD., L.L.P.	12	23

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history